Osthole is a coumarin compound found in the traditional
Chinese
medicine Cnidium monnieri. Extensive
studies have shown that osthole exhibits many medicinal properties,
and recently, researchers have found that it possesses potent airway-relaxation
activity by inhibiting phosphodiesterase 4D activity, making it a
potential novel bronchodilator that does not target β2-adrenoceptors
for asthma treatment. Here, we report the complete biosynthesis of
osthole in engineered yeast. We created an umbelliferone (UMB)-producing
strain by reconstituting the complete UMB pathway in yeast. We found
that coumarin synthase (COSY) is essential for the conversion of 2′,4′-dihydroxycinnamoyl-CoA
into UMB in yeast; this conversion has been treated as a spontaneous
step in previously reported UMB-producing microbials. By introducing
downstream prenyltransferase and methyltransferase genes and addressing
problems such as protein expression and cofactor supply to fulfill
the downstream steps, complete biosynthesis of osthole was achieved.
Finally, through metabolic engineering, to ensure precursor supply,
and the debugging of rate-limited steps, the osthole titer reached
108.10 mg/L in shake flasks and 255.1 mg/L in fed-batch fermentation.
Our study is the first to produce osthole using engineered microbes,
providing a blueprint for the supply of plant-derived osthole via
microbial fermentation, which will remove the barriers of resource
limitations for osthole-based drug development.